InvestorsHub Logo

RandolRocketman

12/22/14 12:10 AM

#7552 RE: rumper #7551

Organovo only needs enough revenue to keep them afloat by selling their services to cover cost for now.
Once they print fully transplant-able therapeutic tissues they will have the enviable problem of trying to meet the demand as the waiting list for donor organs slowly fades into history.
I'mm thinking the first thing might be printed skin grafts for burns, and other tissues for repairing injuries. No more scraping someone's leg for a skin graft, or asking a family member to donate a body part!
If I had stock in a pharma making aniti-rejections drugs, I'd sell them for ONVO soon. But that's me.
I still have to wonder why we haven't heard from the military voicing interest in Organovo's technology. Maybe they already have and no one is saying anything...(?) If/when they do, and if Organovo hasn't been acquired by a larger company by then, ONVO stock price could rocket to unbelievable levels IMHO.
Then it will be too late for them to be bought up cheaply like it is now. It's like, if Ford or GM or even Toyota had bought out Tesla two years ago when they were only a couple billion dollar market cap company. Now at almost $30 billion, it's too late.
I can see where, before you know it, Organovo will have a tissue printing facility in or near every large hospital in the world, just like the pharmacies, or testing labs do now.
If there are any decision makers reading this... time is running out to act. The time for playing this stock is near an end. Either get in and hold tight, or cover your short positions, or make your acquisition now, or watch and get left behind.
Just sayin...